Tg launches 1 Bio, single-use biopharma scale-up hub

The IT Minister announced over `200 crore in new infrastructure upgrades by TGIIC

Hyderabad: In a major boost to India’s biologics and next-generation therapeutics ecosystem, Telangana, on Monday inaugurated 1 Bio, the nation’s first single-use bioprocess design and scale-up facility, marking a pivotal expansion of the Genome Valley innovation cluster. The facility was unveiled by Telangana’s Minister for IT, Electronics & Communications, and Industries & Commerce D Sridhar Babu, who described the launch as the “next wave of growth and leadership” for India’s biopharma sector.

Speaking at the event, Minister Sridhar Babu said, “As Genome Valley marks 25 years, we are setting the course for its next 25 years. 1 Bio is one of India’s most important steps toward democratising access to biologics scale-up and accelerating the journey from discovery to clinical readiness. With this facility, innovations can now advance to pilot and clinical stages in Hyderabad faster, more predictably, and at lower cost.”

To prepare Genome Valley for its next phase of expansion, the Minister announced over Rs200 crore in new infrastructure upgrades by TGIIC, including road widening, new greenfield roads, power augmentation, and landscaping and streetscaping improvements to enhance connectivity and ensure robust utility services within the cluster.

Special Chief Secretary (Industries & ITE&C) Sanjay Kumar highlighted Telangana’s dominant role in national and global life sciences output, noting that the State contributes 40 per cent of India’s pharma production and one-third of global vaccine supply. He said 1 Bio strengthens this leadership by giving innovators access to world-class bioprocess development capacity.

Related Posts

Licences of 20 medical stores suspended after inspections

Drug Control Department inspects 120 medical stores; 32 NDPS cases and 63 arrests recorded in 2026 so far The district administration has intensified action against illegal drug sale and distribution,…

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

NEW DELHI: Global investment firm Bain Capital has divested nearly a 1 per cent stake in Emcure Pharmaceuticals for over Rs 289 crore through open market transactions, according to the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert

Civil society group SAM calls for greater transparency involving clinical trials

Civil society group SAM calls for greater transparency involving clinical trials

Different packaging, typos expose fake Mounjaro racket

Different packaging, typos expose fake Mounjaro racket